EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Theranostic Nanoplatforms in Nuclear Medicine: Current Advances, Emerging Trends, and Perspectives for Personalized Oncology

María Jimena Salgueiro, Marcela Zubillaga

Journal of Nanotheranostics · 03.10.2025 · 6 (4) · 27

DOI: 10.3390/jnt6040027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nanotheranostics, online erschienen am 03.10.2025. Verfasst von María Jimena Salgueiro und 1 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The convergence of nanotechnology with nuclear medicine has led to the development of theranostic nanoplatforms that combine targeted imaging and therapy within a single system. This review provides a critical and updated synthesis of the current state of nanoplatform-based theranostics, with a particular focus on their application in oncology. We explore multifunctional nanocarriers that integrate diagnostic radionuclides for SPECT/PET imaging with therapeutic radioisotopes (α-, β-, or Auger emitters), chemotherapeutics, and biological targeting ligands. We highlight advances in nanomaterial engineering—such as hybrid architectures, surface functionalization, and stimuli-responsive designs—that improve tumor targeting, biodistribution, and therapeutic outcomes. Emphasis is placed on translational challenges including pharmacokinetics, toxicity, regulatory pathways, and GMP-compliant manufacturing. The article closes with a forward-looking perspective on how theranostic nanoplatforms could reshape the future of personalized oncology through precision-targeted diagnostics and radiotherapy.

Zitieren

APA

Salgueiro, M. J., & Zubillaga, M. (2025). Theranostic Nanoplatforms in Nuclear Medicine: Current Advances, Emerging Trends, and Perspectives for Personalized Oncology. Journal of Nanotheranostics, 6(4), 27. https://doi.org/10.3390/jnt6040027

Vancouver

Salgueiro MJ, Zubillaga M. Theranostic Nanoplatforms in Nuclear Medicine: Current Advances, Emerging Trends, and Perspectives for Personalized Oncology. Journal of Nanotheranostics. 2025;6(4):27. doi:10.3390/jnt6040027

BibTeX
@article{Salgueiro2025,
  author = {Salgueiro, María Jimena and Zubillaga, Marcela},
  title = {Theranostic Nanoplatforms in Nuclear Medicine: Current Advances, Emerging Trends, and Perspectives for Personalized Oncology},
  journal = {Journal of Nanotheranostics},
  year = {2025},
  volume = {6},
  number = {4},
  pages = {27},
  doi = {10.3390/jnt6040027}
}
Kostenlos starten →